Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
17 studies found for:    aphasia and university of pennsylvania
Show Display Options
Rank Status Study
1 Completed Transcranial Magnetic Stimulation to Improve Speech in Aphasia
Conditions: Aphasia;   Cerebrovascular Stroke
Intervention: Device: Transcranial Magnetic Stimulation, Repetitive
2 Active, not recruiting Tau Imaging in Young Onset Dementia
Conditions: Alzheimer's Disease, Early Onset;   Logopenic Progressive Aphasia;   Posterior Cortical Atrophy (PCA)
Intervention: Drug: [18F]-T807 imaging tracer
3 Enrolling by invitation Baseline Severity and tDCS in PPA
Condition: Primary Progressive Aphasia
Intervention: Device: transcranial direct current stimulation
4 Recruiting TMS as a Biological Marker of Neuroplasticity
Conditions: Stroke;   Aphasia
Intervention: Device: Transcranial Magnetic Stimulation
5 Recruiting Theory-Driven Treatment of Language and Cognitive Processes in Aphasia
Condition: Aphasia
Intervention: Behavioral: Language Intervention
6 Recruiting Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Conditions: FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
7 Completed Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
Conditions: Memory Disorders;   Alzheimer Disease;   Dementia;   Cognitive Impairment;   Frontotemporal Dementia
Intervention: Device: COGNISION™ System
8 Completed
Has Results
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
Conditions: Frontal Lobe Dementia;   Frontotemporal Lobe Dementia;   Semantic Dementia
Interventions: Drug: memantine;   Drug: Placebo pill
9 Terminated Living With Frontotemporal Dementia
Condition: Adaptation
10 Enrolling by invitation Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Conditions: Alzheimer's Disease;   Behavioral Variant Frontotemporal Dementia
Intervention: Drug: TRx0237
11 Completed Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Condition: Behavioral Variant Frontotemporal Dementia (bvFTD)
Interventions: Drug: TRx0237;   Drug: Placebo
12 Active, not recruiting Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation
Condition: Granulin Mutation
Interventions: Drug: FRM-0334;   Drug: Placebo
13 Recruiting Dosage and Predictors of Naming Treatment Response in Aphasia
Conditions: Aphasia;   Stroke
Intervention: Behavioral: Naming therapy
14 Recruiting Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects
Condition: Familial Frontotemporal Dementia
15 Recruiting Treatment Intensity - Apraxia of Speech
Conditions: Aphasia;   CVA;   Apraxia of Speech
Intervention: Behavioral: Sound Production Treatment (SPT)
16 Recruiting Study of VTS-270 (2-hydroxypropyl-β-cyclodextrin) to Treat Niemann-Pick Type C1 (NPC1) Disease
Condition: Niemann-Pick Disease, Type C
Interventions: Drug: VTS-270;   Drug: Sham Procedure Control
17 Recruiting Music and Adherence Home Programs Post Stroke
Condition: Stroke
Intervention: Behavioral: Preferred music playlist

Indicates status has not been verified in more than two years